| Lu, Linzhi |
NCT04385550: A Study of Anlotinib Hydrochloride Capsule Combined With AK105 Injection in Subject With Advanced Gastric and Gastro-oesophageal Junction Adenocarcinoma |
|
|
| Not yet recruiting | 3 | 528 | RoW | Anlotinib hydrochloride capsule, AK105 injection, Paclitaxel injection, Docetaxel injection | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Advanced Gastric and Gastro-oesophageal Junction Adenocarcinoma | 10/23 | 12/23 | | |
TQB2102-II-04, NCT06767800: A Clinical Trial Evaluating TQB2102 for Injection in Combination With Benmelstobart/Penpulimab With or Without Capecitabine in Unresectable Locally Advanced, Recurrent, or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Gastroesophageal Adenocarcinoma |
|
|
| Not yet recruiting | 2 | 168 | RoW | TQB2102 for injection+Benmelstobart, TQB2102 for injection+Benmelstobart+Capecitabine | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Gastroesophageal Adenocarcinoma | 09/26 | 09/27 | | |
TQH3906-Ib-01, NCT06754891: Clinical Trial of TQH3906 Capsules for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease |
|
|
| Not yet recruiting | 1 | 116 | RoW | TQH3906 capsules | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Inflammatory Bowel Diseases | 12/26 | 12/27 | | |
NCT04242394: If Chronic Gallbladder Diseases Increase the Incidence of PEC |
|
|
| Recruiting | N/A | 152 | RoW | ERCP | Hepatopancreatobiliary Surgery Institute of Gansu Province | Cholecystitis | 10/23 | 10/23 | | |
| Nie, Peng S |
NCT05180734: PD1 Combined With Chemotherapy for Adjuvant Treatment of Gastric Cancer |
|
|
| Active, not recruiting | 3 | 878 | RoW | JS001/Placebo, Postoperative Adjuvant Chemotherapy, JS001/placebo combine with Postoperative Adjuvant Chemotherapy | Shanghai Junshi Bioscience Co., Ltd. | Gastric or Esophagogastric Junction Adenocarcinoma | 06/26 | 07/28 | | |
NCT05246982: HLX07+HLX10+Chemotherapy or HLX07 Monotherapy in Patients With Advanced Metastatic Gastric Cancer |
|
|
| Recruiting | 2 | 40 | RoW | HLX07+HLX10+oxaliplatin+capecitabine, HLX07 | Shanghai Henlius Biotech | Gastric Cancer (GC) Gastroesophageal Junction Cancer (GEJ) | 12/23 | 03/24 | | |
NCT05494359: The Diagnostic Value of Nitrogen Element (N) in Esophagus Cancer |
|
|
| Recruiting | N/A | 120 | RoW | The nitrogen isotope | Hepatopancreatobiliary Surgery Institute of Gansu Province | Esophageal Cancer | 12/23 | 12/23 | | |
NCT04250402: The Incidence of Gallstones After Gastric Cancer Surgery |
|
|
| Recruiting | N/A | 700 | RoW | Resection | Hepatopancreatobiliary Surgery Institute of Gansu Province | Gallstones, Gastric Cancer | 12/23 | 12/23 | | |
NCT05882006: Gallstones and Risk of Inflammatory Bowel Disease |
|
|
| Recruiting | N/A | 5000 | RoW | gallstones | Hepatopancreatobiliary Surgery Institute of Gansu Province | Inflammatory Bowel Diseases | 01/24 | 01/24 | | |
| Recruiting | N/A | 504 | RoW | Distal gastrectomy and radical resection, Total gastrectomy and radical resection | Hepatopancreatobiliary Surgery Institute of Gansu Province | Gallstone, Gastric Cancer | 01/24 | 01/24 | | |
